Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
NCT07651475
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
32
Enrollment
OTHER
Sponsor class
Conditions
R/R AML
Interventions
DRUG:
BCL-2 inhibitor, Zemestosita, Azacitidine, Cytarabine, Chidamide, and G-CSF
Sponsor
Liping Dou